The study followed 18 women undergoing breast augmentation surgery for aesthetic considerations. Baseline pain was established using a 0-10 point visual analog scale. After seven days, baseline pain remained in 7.9 percent of the placebo group versus 38 percent for PRFE treatment.
Related Articles on Pain Management:
North Carolina Hospitals Stop Prescribing, Refilling Pain Medicine in ER
Chondroitin Relives Pain Arthritic Hands
Study: Yoga Improves Back Function in Women With Back Pain
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.